Cardiac Anodal Biphasic Pacing
NCT: NCT07173777 · NOT_YET_RECRUITING
Brief Summary
The goal of this study is to test a new pacing method called anodal biphasic pacing (ABP) to determine if this pacing works as well-or better-than current pacing methods. This new method may improve how the heart works and reduce some of the problems caused by regular pacing. Current implantable pacemakers use a monophasic cathodal waveform to stimulate the heart. Monophasic cathodal pacing (MCP) waveforms slow conduction, impair contractility, cause inflammation, increase risk of atrial fibrillation, heart failure, and mortality. Anodal biphasic pacing (ABP) is an alternative waveform that can stimulate the heart. ABP preconditions the heart and then initiates cardiac contraction. ABP may address the limitations of MCP.
Frequently Asked Questions
What is Cardiac Anodal Biphasic Pacing?
Cardiac Anodal Biphasic Pacing is a clinical trial registered under NCT07173777. Current status: NOT_YET_RECRUITING.
What is the status of NCT07173777?
The current status of NCT07173777 (Cardiac Anodal Biphasic Pacing) is: NOT_YET_RECRUITING.
When did Cardiac Anodal Biphasic Pacing start?
Cardiac Anodal Biphasic Pacing started on 2026-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.